Q3 2010

Filed Nov 15, 2010 · 10-Q · 46 days after period end · 0001477932-10-000875

Q3 2010 · 10-Q

Revenue—

Net Income

-$5.61K

no prior Q3 2009 on file

EPS Diluted

$0.00

no prior Q3 2009 on file

Operating Income-$5,613—

Operating Cash Flowderived-$38,901—

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 15, 2010 · 46 d after period end

Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR